AAV2-hAQP1 gene therapy

AAV2-hAQP1 · MeiraGTx, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AAV2-hAQP1 gene therapy, covering 2026-02-02 to 2026-02-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia [Phase 2]